Clinical trial
Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease…
NCT00038558 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00038558 |
|---|---|
| Title | Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy |
| Official title | Prophylactic Use of Filgrastim SD/01 In Patients With Hodgkin's Disease Receiving ABVD Chemotherapy |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hodgkin Disease |
| Intervention type | Drug |
| Interventions | Filgrastim SD/01, Adriamycin, Bleomycin, Vinblastine, DTIC |
| Enrollment | 25 |
| Start date | Nov 1, 2001 |
| Primary completion | Feb 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Jun 3, 2002 |
| Last update posted | Oct 31, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: